My name is Rabbi Josh Ratner and I am the Director of Advocacy at JLens, a Jewish values-based investor network that owns thousands of shares of Merck. We applaud Merck for its pharmaceutical applications, vaccine research, and access to medicine programs that offer affordable drug pricing to developing nations, and we encourage Merck to continue working on product safety and corporate governance oversight. We urge our fellow shareholders to vote AGAINST Proposals 6 & 7. Whil